Dai, Yao <br/><br/>
DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathway.  [electronic resource] 

 -  Acta diabetologica  2014 
 - 471-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1432-5233 
<br/><br/><label>Standard No.: </label>10.1007/s00592-013-0541-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Atherosclerosis--drug therapy<br/>Cell Line<br/>Dipeptidyl Peptidase 4--genetics<br/>Dipeptidyl-Peptidase IV Inhibitors--pharmacology<br/>Down-Regulation--drug effects<br/>Foam Cells--drug effects<br/>Humans<br/>Lipoproteins, LDL--metabolism<br/>Macrophages--drug effects<br/>Protein Kinase C--metabolism<br/>Pyrazines--pharmacology<br/>Receptors, Scavenger--genetics<br/>Sitagliptin Phosphate<br/>Triazoles--pharmacology